Evidence map›Paper›PMID 35025956›Full record

ArticlePloS one2022

Comparative analysis of DNA extraction and PCR product purification methods for cervicovaginal microbiome analysis using cpn60 microbial profiling.

Elinor Shvartsman, Meika E I Richmond, John J Schellenberg, Alana Lamont, Catia Perciani, Justen N H Russell, Vanessa Poliquin, Adam Burgener, Walter Jaoko, Paul Sandstrom and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. RAPD Markers for the Study of Genetic Diversity in Echium amoenum Ecotypes.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Frontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Elinor ShvartsmanDepartment of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.ORCID 0000-0001-6456-2836
Meika E I RichmondDepartment of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
John J SchellenbergJC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.ORCID 0000-0003-3970-1608
Alana LamontCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, United States of America.
Catia PercianiDepartment of Immunology, University of Toronto, Toronto, Canada.
Justen N H RussellJC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.ORCID 0000-0002-5275-0116
Vanessa PoliquinDepartment of Obstetrics and Gynecology, University of Manitoba, Winnipeg, Canada.ORCID 0000-0003-0526-3902
Adam BurgenerCenter for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, United States of America.
Walter JaokoKenyan AIDS Vaccine Initiative-Institute of Clinical Research (KAVI-ICR), University of Nairobi, Nairobi, Kenya.
Paul SandstromJC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Kelly S MacDonaldDepartment of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.ORCID 0000-0003-3216-247X
Public Health Agency of Canada · CACenter for Global Health · USKarolinska Institutet · SEUniversity of Manitoba · CAUniversity of Nairobi · KEUniversity of Toronto · CA

Funding

CIHR
6 · The paper itself

Abstract

backgroundThe microbiota of the lower female genital tract plays an important role in women's health. Microbial profiling using the chaperonin60 (cpn60) universal target (UT) improves resolution of vaginal species associated with negative health outcomes compared to the more commonly used 16S ribosomal DNA target. However, the choice of DNA extraction and PCR product purification methods may bias sequencing-based microbial studies and should be optimized for the sample type and molecular target used. In this study, we compared two commercial DNA extraction kits and two commercial PCR product purification kits for the microbial profiling of cervicovaginal samples using the cpn60 UT.

methodsDNA from cervicovaginal secretions and vaginal lavage samples as well as mock community standards were extracted using either the specialized QIAamp DNA Microbiome Kit, or the standard DNeasy Blood & Tissue kit with enzymatic pre-treatment for enhanced lysis of gram-positive bacteria. Extracts were PCR amplified using well-established cpn60 primer sets and conditions. Products were then purified using a column-based method (QIAquick PCR Purification Kit) or a gel-based PCR clean-up method using the QIAEX II Gel Extraction Kit. Purified amplicons were sequenced with the MiSeq platform using standard procedures. The overall quality of each method was evaluated by measuring DNA yield, alpha diversity, and microbial composition.

resultsDNA extracted from cervicovaginal samples using the DNeasy Blood and Tissue kit, pre-treated with lysozyme and mutanolysin, resulted in increased DNA yield, bacterial diversity, and species representation compared to the QIAamp DNA Microbiome kit. The column-based PCR product purification approach also resulted in greater average DNA yield and wider species representation compared to a gel-based clean-up method. In conclusion, this study presents a fast, effective sample preparation method for high resolution cpn60 based microbial profiling of cervicovaginal samples.

Indexed as

BacteriaDNADNA, BacterialFemaleHumansMicrobiotaNucleic Acid Amplification TechniquesPolymerase Chain ReactionRNA, Ribosomal, 16SSequence Analysis, DNASpecimen HandlingVaginaDNADNA, BacterialRNA, Ribosomal, 16S

Identifiers

PMID35025956
PMCPMC8758110
OpenAlexW4206715252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.